Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.64B |
| 2 |
Microsoft
MSFT
|
+$1.44B |
| 3 |
NVIDIA
NVDA
|
+$1.17B |
| 4 |
Gilead Sciences
GILD
|
+$1.08B |
| 5 |
Eli Lilly
LLY
|
+$996M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.21B |
| 3 |
United Parcel Service
UPS
|
+$1.06B |
| 4 |
T-Mobile US
TMUS
|
+$908M |
| 5 |
McDonald's
MCD
|
+$883M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.86% |
| 2 | Financials | 15.98% |
| 3 | Healthcare | 15.38% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Autohome
ATHM
$2.67B
| $1.1M | ﹤0.01% |
+42,590
| New | +$1.1M |
|
1602
Park Aerospace
PKE
$737M
| $1.1M | ﹤0.01% |
74,332
-1,568
| -2% | -$21.2K |
|
1603
eBay
EBAY
$50.6B
| $1.09M | ﹤0.01% |
14,689
+6,757
| +85% | +$479K |
|
|
ATYR
1604
aTyr Pharma
ATYR
$47.6M
| $1.09M | ﹤0.01% |
214,928
+46,186
| +27% | +$182K |
|
1605
Prudential Financial
PRU
$42.4B
| $1.08M | ﹤0.01% |
10,007
+4,832
| +93% | +$501K |
|
1606
iShares MSCI Hong Kong ETF
EWH
$1.24B
| $1.07M | ﹤0.01% |
54,028
+38,305
| +244% | +$700K |
|
1607
Moderna
MRNA
$21.8B
| $1.07M | ﹤0.01% |
38,805
-2,856,750
| -99% | -$75.2M |
|
1608
Acadia Pharmaceuticals
ACAD
$4.43B
| $1.07M | ﹤0.01% |
49,598
-2,177
| -4% | -$40.5K |
|
1609
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.5B
| $1.06M | ﹤0.01% |
9,772
-338
| -3% | -$34.6K |
|
1610
Acrivon Therapeutics
ACRV
$64.2M
| $1.06M | ﹤0.01% |
888,130
| – | – |
|
1611
Descartes Systems
DSGX
$6.44B
| $1.05M | ﹤0.01% |
10,384
+27
| +0.3% | +$2.85K |
|
|
ATXS
1612
DELISTED
Astria Therapeutics
ATXS
| $1.04M | ﹤0.01% |
193,749
+41,138
| +27% | +$199K |
|
1613
Global Payments
GPN
$23B
| $1.03M | ﹤0.01% |
12,852
-372,371
| -97% | -$29.5M |
|
|
LENZ
1614
LENZ Therapeutics
LENZ
$166M
| $1.02M | ﹤0.01% |
34,827
+4,339
| +14% | +$118K |
|
1615
Heron Therapeutics
HRTX
$93.9M
| $1.02M | ﹤0.01% |
493,083
+5,841
| +1% | +$11.9K |
|
1616
Monte Rosa Therapeutics
GLUE
$1.4B
| $1.01M | ﹤0.01% |
224,818
+37,087
| +20% | +$165K |
|
1617
MoonLake Immunotherapeutics
MLTX
$1.57B
| $1.01M | ﹤0.01% |
21,390
-10,773
| -33% | -$439K |
|
|
CPRX
1618
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.01M | ﹤0.01% |
46,359
-2,088
| -4% | -$49.3K |
|
1619
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$41.4B
| $994K | ﹤0.01% |
+8,958
| New | +$781K |
|
1620
Abeona Therapeutics
ABEO
$366M
| $991K | ﹤0.01% |
174,514
+21,393
| +14% | +$122K |
|
1621
ICL Group
ICL
$6.53B
| $987K | ﹤0.01% |
143,929
-344,408
| -71% | -$2.25M |
|
1622
Tyra Biosciences
TYRA
$1.9B
| $986K | ﹤0.01% |
103,078
-1,009
| -1% | -$9.59K |
|
1623
Equity Lifestyle Properties
ELS
$12.6B
| $980K | ﹤0.01% |
15,897
+293
| +2% | +$18.7K |
|
|
GAP
1624
The Gap Inc
GAP
$7.23B
| $979K | ﹤0.01% |
+44,891
| New | +$1M |
|
1625
Altimmune
ALT
$552M
| $975K | ﹤0.01% |
251,866
+26,912
| +12% | +$146K |
|
Similar funds
Wellington Management Group's Q2 2025 Portfolio in Review
As of Q2 2025, Wellington Management Group held 2,080 positions worth $551B, up 6% from $520B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Wellington Management Group's Q2 2025 filing shows 139 new, 795 increased, 834 reduced and 147 closed positions. Its largest new stake was Amrize Ltd: 7,812,891 shares worth $388M. The largest sale was Procter & Gamble, an estimated $1.38B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Wellington Management Group's largest Q2 2025 buy was Amrize Ltd: 7,812,891 shares worth $388M.
- Wellington Management Group added most to Alphabet (Google) Class A in Q2 2025, an estimated $1.64B increase.
- Wellington Management Group's biggest Q2 2025 reduction was Procter & Gamble, cutting an estimated $1.38B.
- Wellington Management Group fully exited iShares Russell 1000 Growth ETF in Q2 2025, selling an estimated $464M.
- Wellington Management Group's ten largest holdings make up 25% of its $551B portfolio in Q2 2025.
- Wellington Management Group opened 139 new positions and closed 147 in Q2 2025.
- Wellington Management Group's portfolio value rose 6% quarter-over-quarter to $551B.
Based on Wellington Management Group's 13F filing for Q2 2025, filed 14 Aug 2025.